Markus Wagener - JoVE Visualize

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Filters

Markus Wagener

Showing results (11-20 of 13) with videos related to

Pageof 2

Sort By:

You have reached the last page of results.This site can display upto 13 results.

Journal of Medicinal Chemistry|June 28, 2019

Fragment-Based Discovery of Novel Potent Sepiapterin Reductase InhibitorsJo Alen, Markus Schade, Markus Wagener, et al.

Drug Discovery Today|January 20, 2024

The European Lead Factory: Results from a decade of collaborative, public-private, drug discovery programsHerman van Vlijmen, Andrew D Pannifer, Phil Cochrane, et al.

ACS Medicinal Chemistry Letters|May 20, 2026

Discovery and Optimization of Potent and Subtype-Selective Urea-Derived Na<sub>V</sub>1.8 InhibitorsClemens Dialer, Sebastian Krüger, Markus Wagener, et al.

Pageof 2

Search research articles

Showing results (11-20 of 13) with videos related to

Sort By:

Pageof 2

You have reached the last page of results.This site can display upto 13 results.

Journal of Medicinal Chemistry|June 28, 2019

Fragment-Based Discovery of Novel Potent Sepiapterin Reductase InhibitorsJo Alen, Markus Schade, Markus Wagener, et al.

Drug Discovery Today|January 20, 2024

The European Lead Factory: Results from a decade of collaborative, public-private, drug discovery programsHerman van Vlijmen, Andrew D Pannifer, Phil Cochrane, et al.

ACS Medicinal Chemistry Letters|May 20, 2026

Discovery and Optimization of Potent and Subtype-Selective Urea-Derived Na<sub>V</sub>1.8 InhibitorsClemens Dialer, Sebastian Krüger, Markus Wagener, et al.

Pageof 2